Erratum to: Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region [Rheumatology International, DOI 10.1007/s00296-014-3087-y];Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region

Rheumatology International

Volumn 35, Issue 3, 2015, Pages 509-515

  Salman Monte, Tarek Carlos ^a   Torrente Segarra, Vicenç ^a,b   Muñoz Ortego, Juan ^c   Mojal, Sergi ^d   Carbonell Abelló, Jordi ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^d Unitat de Assessorament Metodològic a la Investigació   (Spain)

Author keywords

Body weight; Bone density; Fractures; SLEDAI; Systemic lupus erythematosus

Indexed keywords

25-HYDROXYVITAMIN D; ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT; VITAMIN D;

ADULT; AGED; ANALOGS AND DERIVATIVES; BLOOD; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDY; FEMALE; FEMUR NECK; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PHOTON ABSORPTIOMETRY; PREVALENCE; RADIOGRAPHY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPAIN;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTIRHEUMATIC AGENTS; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; FEMALE; FEMUR NECK; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; VITAMIN D;

EID: 84939874610     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3217-1     Document Type: Erratum

References (23)

1. Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R (2011) Bone geometry profiles in women with and without SLE. J Bone Miner Res 26:2719–2726
2. Roux C (2011) Osteoporosis in inflammatory joint diseases. Osteoporos Int 22:421–433
3. Yee CS, Crabtree N, Skan J et al (2005) Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64:111–114
4. Jacobs J, Korswagen LA, Schilder AM et al (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827–1833
5. Dhillon VB, Davies MC, Hall ML et al (1990) Assessment of the effects of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X-ray absorptiometry. Ann Rheum Dis 149:624–626
6. Almehed K, Forsblad d’Elia H, Kvist G, Ohlsson C, Carlsten H (2007) Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford) 46:1185–1190
7. Yeap SS, Othman AZ, Zain AA, Chan SP (2012) Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int J Rheum Dis 15:17–24
8. Becker A, Fischer R, Scherbaum WA, Schneider M (2001) Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus 10:809–814
9. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
10. Zhang FZ, Su MH, Li P (2012) Bone mineral density and disease activity in untreated systemic lupus erythematosus patients. Zhonghua Yi Xue Za Zhi 92:2331–2334
11. Ward MM, Marx AS, Barry NN (2000) Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 27:664–670
12. Gladman DD, Goldsmith CH, Urowitz MB et al (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27:373–376
13. Milligan SE, Hom DL, Ballou SP et al (1993) An assessment of the Health Assessment Questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 20:972–976
14. Edworthy SM (2005) Clinical manifestations of systemic lupus erythematosus. In: Harris ED, Budd RC, Firestein GS (eds) Kelley’s textbook of rheumatology. Elsevier Saunders, US, pp 1201–1224
15. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E (1997) Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 24:1922–1929
16. Bultink IE, Vis M, van der Horst-Bruinsma IE, Lems WF (2012) Inflammatory rheumatic disorders and bone. Curr Rheumatol Rep 14:224–230
17. Méndez JP, Rojano-Mejía D, Pedraza J et al (2012) Bone mineral density in postmenopausal Mexican-Mestizo women with normal body mass index, overweight, or obesity. Menopause 20:568–572
18. Mok CC, Ying SK, To CH, Ma KM (2008) Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone 43:327–331
19. Muñoz-Ortego J, Torrente-Segarra V, Prieto-Alhambra D, Salman-Monte TC, Carbonell-Abello J (2012) Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study. Scand J Rheumatol 41:472–475
20. Li EK, Tam LS, Griffith JF et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646–1652
21. Steinbuch M, Youket TE, Cohens S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15:323–328
22. Lee C, Almagor O, Dunlop DD et al (2006) Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 45:53–60
23. Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG (1999) Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 18:137–140